ESPAC-3(v2): A multicenter, international, open-label, randomized, controlled phase III trial of adjuvant 5-fluorouracil/folinic acid (5-FU/FA) versus gemcitabine (GEM) in patients with resected pancreatic ductal adenocarcinoma

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Author(s): Neoptolemos J, Buchler M, Stocken DD, Ghaneh P, Smith D, Bassi C, Moore M, Cunningham D, Dervenis C, Goldstein D

Publication type: Conference Proceedings (inc. Abstract)

Publication status: Published

Conference Name: 45th Annual Meeting of the American Society of Clinical Oncology

Year of Conference: 2009

Pages: LBA4505

ISSN: 0732-183X

Publisher: American Society of Clinical Oncology

Library holdings: Search Newcastle University Library for this item

Series Title: Journal of Clinical Oncology

ISBN: 15277755

ePrints